Literature DB >> 12669373

Macrolide antibiotic interaction and resistance on the bacterial ribosome.

Jacob Poehlsgaard1, Stephen Douthwaite.   

Abstract

Our understanding of the fine structure of many antibiotic target sites has reached a new level of enlightenment in the last couple of years due to the advent, by X-ray crystallography, of high-resolution structures of the bacterial ribosome. Many classes of clinically useful antibiotics bind to the ribosome to inhibit bacterial protein synthesis. Macrolide, lincosamide and streptogramin B (MLSB) antibiotics form one of the largest groups, and bind to the same site on the 50S ribosomal subunit. Here, we review the molecular details of the ribosomal MLSB site to put into perspective the main points from a wealth of biochemical and genetic data that have been collected over several decades. The information is now available to understand, at atomic resolution, how macrolide antibiotics interact with their ribosomal target, how the target is altered to confer resistance, and in which directions we need to look if we are to rationally design better drugs to overcome the extant resistance mechanisms.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12669373

Source DB:  PubMed          Journal:  Curr Opin Investig Drugs        ISSN: 1472-4472


  12 in total

Review 1.  Taxonomy, Physiology, and Natural Products of Actinobacteria.

Authors:  Essaid Ait Barka; Parul Vatsa; Lisa Sanchez; Nathalie Gaveau-Vaillant; Cedric Jacquard; Jan P Meier-Kolthoff; Hans-Peter Klenk; Christophe Clément; Yder Ouhdouch; Gilles P van Wezel
Journal:  Microbiol Mol Biol Rev       Date:  2015-11-25       Impact factor: 11.056

2.  Emergence of macrolide-resistant Mycoplasma pneumoniae with a 23S rRNA gene mutation.

Authors:  Miyuki Morozumi; Keiko Hasegawa; Reiko Kobayashi; Nagako Inoue; Satoshi Iwata; Haruo Kuroki; Naohisa Kawamura; Eiichi Nakayama; Takeshi Tajima; Kouichi Shimizu; Kimiko Ubukata
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191

3.  Multiple defects in translation associated with altered ribosomal protein L4.

Authors:  Michael O'Connor; Steven T Gregory; Albert E Dahlberg
Journal:  Nucleic Acids Res       Date:  2004-10-27       Impact factor: 16.971

Review 4.  The macrolide antibiotic renaissance.

Authors:  George P Dinos
Journal:  Br J Pharmacol       Date:  2017-08-10       Impact factor: 8.739

5.  Binding and action of CEM-101, a new fluoroketolide antibiotic that inhibits protein synthesis.

Authors:  Beatriz Llano-Sotelo; Jack Dunkle; Dorota Klepacki; Wen Zhang; Prabhavathi Fernandes; Jamie H D Cate; Alexander S Mankin
Journal:  Antimicrob Agents Chemother       Date:  2010-09-20       Impact factor: 5.191

6.  Chalcomycin biosynthesis gene cluster from Streptomyces bikiniensis: novel features of an unusual ketolide produced through expression of the chm polyketide synthase in Streptomyces fradiae.

Authors:  Shannon L Ward; Zhihao Hu; Andreas Schirmer; Ralph Reid; W Peter Revill; Christopher D Reeves; Oleg V Petrakovsky; Steven D Dong; Leonard Katz
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

7.  Ketolide antimicrobial activity persists after disruption of interactions with domain II of 23S rRNA.

Authors:  Guy W Novotny; Lene Jakobsen; Niels M Andersen; Jacob Poehlsgaard; Stephen Douthwaite
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

8.  A target site for template-based design of measles virus entry inhibitors.

Authors:  Richard K Plemper; Karl J Erlandson; Ami S Lakdawala; Aiming Sun; Andrew Prussia; Jutatip Boonsombat; Esin Aki-Sener; Ismail Yalcin; Ilkay Yildiz; Ozlem Temiz-Arpaci; Betul Tekiner; Dennis C Liotta; James P Snyder; Richard W Compans
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-31       Impact factor: 11.205

9.  Dihydrochalcomycin Production and Glycosyltransferase from Streptomyces SP. KCTC 0041BP.

Authors:  Ta Thi Thu Thuy; Jae Kyung Sohng; Blaine Pfeifer
Journal:  EJIFCC       Date:  2010-01-26

10.  Insights into the mode of action of novel fluoroketolides, potent inhibitors of bacterial protein synthesis.

Authors:  Marios G Krokidis; Viter Márquez; Daniel N Wilson; Dimitrios L Kalpaxis; George P Dinos
Journal:  Antimicrob Agents Chemother       Date:  2013-11-04       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.